Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
662
-
Total 13F shares, excl. options
-
71.2M
-
Shares change
-
+1.14M
-
Total reported value, excl. options
-
$13.2B
-
Value change
-
+$163M
-
Put/Call ratio
-
1.31
-
Number of buys
-
266
-
Number of sells
-
-347
-
Price
-
$186.02
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2018
784 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2018.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 662 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.2M shares
of 80.8M outstanding shares and own 88.08% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (9.06M shares), BlackRock Inc. (6.55M shares), BAMCO INC /NY/ (4.13M shares), STATE STREET CORP (3.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.37M shares), BLAIR WILLIAM & CO/IL (1.57M shares), AMERIPRISE FINANCIAL INC (1.54M shares), GOLDMAN SACHS GROUP INC (1.53M shares), RENAISSANCE TECHNOLOGIES LLC (1.52M shares), and Neuberger Berman Group LLC (1.51M shares).
This table shows the top 662 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.